Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.

Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...

The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

Chair Lina Khan’s aggressive stance on antitrust has been widely criticized by corporate America. But it’s also won her ...

The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...

Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, ...

The Federal Trade Commission on Friday filed a lawsuit over insulin prices against the three largest pharmaceutical middlemen ...

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...

Antitrust regulation isn't just about protecting consumers, Federal Trade Commission Chair Lina Khan said Thursday afternoon ...

A new FTC report on how social media and streaming sites collect and monetize their hoards of user data doesn't really ...